ANIXA BIOSCIENCES, INC. Gain (Loss) on Extinguishment of Debt
ANIXA BIOSCIENCES, INC. (ANIX) reported Gain (Loss) on Extinguishment of Debt of $1.55 million for the 12-month period ending 2017-10-31, per its 10-K filed 2019-01-11.
Discontinued › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2019-01-11
- ANIXA BIOSCIENCES, INC. gain (loss) on extinguishment of debt for the quarter ending 2017-10-31 was $0.00.
- ANIXA BIOSCIENCES, INC. gain (loss) on extinguishment of debt for the quarter ending 2017-07-31 was $0.00.
- ANIXA BIOSCIENCES, INC. gain (loss) on extinguishment of debt for the quarter ending 2017-04-30 was $1.55M.
- ANIXA BIOSCIENCES, INC. gain (loss) on extinguishment of debt for the quarter ending 2014-10-31 was -$2.22M.
- ANIXA BIOSCIENCES, INC. gain (loss) on extinguishment of debt for fiscal 2017 was $1.55M.
- ANIXA BIOSCIENCES, INC. gain (loss) on extinguishment of debt for fiscal 2014 was -$2.70M.
- ANIXA BIOSCIENCES, INC. gain (loss) on extinguishment of debt for fiscal 2013 was -$343.52K.
| Period end | Gain (Loss) on Extinguishment of Debt | Gain (Loss) on Extinguishment of Debt 3 month | Gain (Loss) on Extinguishment of Debt 6 month | Gain (Loss) on Extinguishment of Debt 9 month | Gain (Loss) on Extinguishment of Debt 12 month | Gain (Loss) on Extinguishment of Debt 12 month as first filed |
|---|---|---|---|---|---|---|
| 2017-10-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-01-11 | $0.00 derived: sum of 2 quarters · filed 2019-01-11 | $1.55M derived: sum of 3 quarters · filed 2019-01-11 | $1.55M 10-K · filed 2019-01-11 | ||
| 2017-07-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-09-07 | $1.55M derived: sum of 2 quarters · filed 2018-09-07 | $1.55M 10-Q · filed 2018-09-07 | |||
| 2017-04-30 | $1.55M 10-Q · filed 2018-06-11 | $1.55M 10-Q · filed 2018-06-11 | ||||
| 2017-03-27 | $1.55M 10-Q · filed 2018-06-11 | |||||
| 2014-10-31 | -$2.22M derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-23 | -$2.22M derived: sum of 2 quarters · filed 2015-12-23 | -$2.70M derived: sum of 3 quarters · filed 2015-12-23 | -$2.70M 10-K · filed 2015-12-23 | ||
| 2014-07-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-18 | -$482.92K derived: sum of 2 quarters · filed 2015-08-18 | -$482.92K 10-Q · filed 2015-08-18 | |||
| 2014-04-30 | -$482.92K 10-Q · filed 2015-05-22 | -$482.92K 10-Q · filed 2015-05-22 | ||||
| 2013-10-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-01-29 | -$343.52K derived: sum of 2 quarters · filed 2015-01-29 | -$343.52K 10-K · filed 2015-01-29 | $343.52K 10-K/A · filed 2014-01-17 | ||
| 2013-07-31 | -$343.52K 10-Q · filed 2014-09-15 | -$343.52K 10-Q · filed 2014-09-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |